Search results
Newswise Expert | Daniel Petrylak, Yale Cancer Center/Smilow Cancer Hospital
Newswise· 5 days agoDaniel P. Petrylak is a pioneer in the research and development of new drugs and treatments to fight prostate, bladder, kidney and testicular cancer. For ...
Scores of cancer survivors celebrate at CBCC
The Bakersfield Californian via Yahoo News· 3 days agoMore than 40 local cancer survivors celebrated their lives and those of others like them around the world at an annual event hosted Monday afternoon by Comprehensive Blood ...
FDA confirms robotic prostatectomy survival rates match traditional surgery By Investing.com
Investing.com· 1 day agoThe U.S. Food and Drug Administration (FDA) has approved a labeling revision for Intuitive's da...
Gamechanging blood test predicts breast cancer relapse up to three years early
Daily Express· 5 days agoAn “ultra-sensitive” blood test can predict which breast cancer survivors will relapse years before...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 2 days agoThe vaccine, which he received four times, will hopefully keep him from developing prostate, breast...
Experimental therapy shows promise in pancreatic cancer clinical trial
Medical Xpress· 6 days agoIt acts by inflaming the microenvironment surrounding the tumor and thereby augmenting the activity...
What is the healthiest fruit? The No. 1 pick, according to a dietitian
TODAY via Yahoo News· 2 days agoWhat is the healthiest fruit? Blueberries top the list of healthiest fruits for weight loss, heart...
With New Validation Data, BillionToOne Boosts Commercial Prospects of Therapy Selection Assay
GenomeWeb News· 10 hours agoThe 84-gene genomic alteration panel covers all solid tumor alterations associated with US Food and Drug Administration-approved targeted therapies and immunotherapies, including ...
“Monstrous” Discovery: Scientists Identify Key to Stopping Cancer Recurrence
SciTechDaily· 3 days agoScientists have discovered that polyploid giant cancer cells, which are monstrously oversized and...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 days agoFDA Approved Phase II/III Clinical Study of KPG-121 in Combination with Abiraterone as a First Line Treatment for mCRPC PR Newswire HEFEI, China, June 5, 2024 HEFEI, China, June 5, 2024 /PRNewswire/ -- Kangpu Biopharmaceuticals today announced that
